BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37280059)

  • 1. A neuropsychological approach to differentiating cannabis-induced and primary psychotic disorders.
    Woolridge SM; Wood-Ross C; Voleti R; Harrison GW; Berisha V; Bowie CR
    Early Interv Psychiatry; 2023 Jun; 17(6):564-572. PubMed ID: 37280059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cannabis and stimulant disorders on diagnostic stability in psychosis.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    J Clin Psychiatry; 2014 Apr; 75(4):349-56. PubMed ID: 24813404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use related to early psychotic onset: Role of premorbid function.
    Frascarelli M; Quartini A; Tomassini L; Russo P; Zullo D; Manuali G; De Filippis S; Bersani G
    Neurosci Lett; 2016 Oct; 633():55-61. PubMed ID: 27637389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
    Hides L; Kavanagh DJ; Dawe S; Young RM
    Drug Alcohol Rev; 2009 May; 28(3):250-6. PubMed ID: 18608451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis users have higher premorbid IQ than other patients with first onset psychosis.
    Ferraro L; Russo M; O'Connor J; Wiffen BD; Falcone MA; Sideli L; Gardner-Sood P; Stilo S; Trotta A; Dazzan P; Mondelli V; Taylor H; Friedman B; Sallis H; La Cascia C; La Barbera D; David AS; Reichenberg A; Murray RM; Di Forti M
    Schizophr Res; 2013 Oct; 150(1):129-35. PubMed ID: 23958486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of cannabis exposure during early versus later adolescence on the expression of psychosis in homeless and precariously housed adults.
    Gicas KM; Cheng A; Panenka WJ; Kim DD; Yau JC; Procyshyn RM; Stubbs JL; Jones AA; Bains S; Thornton AE; Lang DJ; Vertinsky AT; Rauscher A; Honer WG; Barr AM
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110084. PubMed ID: 32890696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Motivational interviewing for cannabis users with psychotic disorders].
    Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
    Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.
    Compton MT; Broussard B; Ramsay CE; Stewart T
    Schizophr Res; 2011 Mar; 126(1-3):71-6. PubMed ID: 21036542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premorbid characteristics of patients with DSM-IV psychotic disorders.
    Widing L; Simonsen C; Flaaten CB; Haatveit B; Vik RK; Wold KF; Åsbø G; Ueland T; Melle I
    Compr Psychiatry; 2022 May; 115():152310. PubMed ID: 35385814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
    Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics.
    Fitzgerald D; Lucas S; Redoblado MA; Winter V; Brennan J; Anderson J; Harris A
    Aust N Z J Psychiatry; 2004 Jul; 38(7):501-10. PubMed ID: 15255822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review.
    Wilson L; Szigeti A; Kearney A; Clarke M
    Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.